US 10,287,259 B2Granted

Selenazolidine and thiazolidine compounds for treating cancer and other diseases

AssigneeThe Penn State Research Foundation

InventorsArun K. Sharma, Shantu Amin, Daniel Plano, Deepkamal Karelia

Life of this patent

Estimating the term…

Abstract

The present invention includes compounds useful in preventing or treating cancer in a subject in need thereof. The present invention also includes methods of preventing or treating cancer in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of the invention.

Claims6

Dependent claims

A compound selected from the group consisting of:

a salt or solvate thereof, and any combinations thereof.

Dependencies are inferred from the claim text.

Facts

Application: 15/457,587Filed 13 Mar 2017 · us provisional application
Priority: 14 Mar 2016
Published: US 2017/0260151 A114 Sep 2017
Granted: 14 May 2019
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

C07D 293/06
Five-membered rings: selenazoles; Hydrogenated selenazoles
A61K 31/41
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having five-membered rings with two or more ring hetero atoms, at least…
A61K 31/426
Thiazoles: 1,3-Thiazoles
A61K 31/7068
Containing condensed or non-condensed pyrimidines: having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid

Family

Application62/307,923Us provisional application · filed 14 Mar 2016
US 2017/0260151 A1Pre-grant publication · published 14 Sep 2017
US 10,287,259 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results